Functional Expression of Choline Transporters in the Blood-Brain Barrier
- PMID: 31547050
- PMCID: PMC6835570
- DOI: 10.3390/nu11102265
Functional Expression of Choline Transporters in the Blood-Brain Barrier
Abstract
Cholinergic neurons in the central nervous system play a vital role in higher brain functions, such as learning and memory. Choline is essential for the synthesis of the neurotransmitter acetylcholine by cholinergic neurons. The synthesis and metabolism of acetylcholine are important mechanisms for regulating neuronal activity. Choline is a positively charged quaternary ammonium compound that requires transporters to pass through the plasma membrane. Currently, there are three groups of choline transporters with different characteristics, such as affinity for choline, tissue distribution, and sodium dependence. They include (I) polyspecific organic cation transporters (OCT1-3: SLC22A1-3) with a low affinity for choline, (II) high-affinity choline transporter 1 (CHT1: SLC5A7), and (III) choline transporter-like proteins (CTL1-5: SLC44A1-5). Brain microvascular endothelial cells, which comprise part of the blood-brain barrier, take up extracellular choline via intermediate-affinity choline transporter-like protein 1 (CTL1) and low-affinity CTL2 transporters. CTL2 is responsible for excreting a high concentration of choline taken up by the brain microvascular endothelial cells on the brain side of the blood-brain barrier. CTL2 is also highly expressed in mitochondria and may be involved in the oxidative pathway of choline metabolism. Therefore, CTL1- and CTL2-mediated choline transport to the brain through the blood-brain barrier plays an essential role in various functions of the central nervous system by acting as the rate-limiting step of cholinergic neuronal activity.
Keywords: acetylcholine; blood–brain barrier; brain microvascular endothelial cells; central nervous system; choline; transporter.
Conflict of interest statement
The author declares no conflicts of interest.
Figures
Similar articles
-
Functional expression of choline transporter like-protein 1 (CTL1) and CTL2 in human brain microvascular endothelial cells.Neurochem Int. 2016 Feb;93:40-50. doi: 10.1016/j.neuint.2015.12.011. Epub 2015 Dec 31. Neurochem Int. 2016. PMID: 26746385
-
Choline transporter-like proteins 1 and 2 are newly identified plasma membrane and mitochondrial ethanolamine transporters.J Biol Chem. 2021 Jan-Jun;296:100604. doi: 10.1016/j.jbc.2021.100604. Epub 2021 Mar 28. J Biol Chem. 2021. PMID: 33789160 Free PMC article.
-
The ubiquitous choline transporter SLC44A1.Cent Nerv Syst Agents Med Chem. 2012 Jun;12(2):70-81. doi: 10.2174/187152412800792733. Cent Nerv Syst Agents Med Chem. 2012. PMID: 22483272 Review.
-
Detection of choline transporter-like 1 protein CTL1 in neuroblastoma x glioma cells and in the CNS, and its role in choline uptake.J Neurochem. 2009 Aug;110(4):1297-309. doi: 10.1111/j.1471-4159.2009.06218.x. Epub 2009 Jun 10. J Neurochem. 2009. PMID: 19519661
-
Choline transport for phospholipid synthesis.Exp Biol Med (Maywood). 2006 May;231(5):490-504. doi: 10.1177/153537020623100503. Exp Biol Med (Maywood). 2006. PMID: 16636297 Review.
Cited by
-
The emerging roles of neuroactive components produced by gut microbiota.Mol Biol Rep. 2024 Nov 21;52(1):1. doi: 10.1007/s11033-024-10097-4. Mol Biol Rep. 2024. PMID: 39570444 Review.
-
Gut microbiota metabolites: potential therapeutic targets for Alzheimer's disease?Front Pharmacol. 2024 Sep 17;15:1459655. doi: 10.3389/fphar.2024.1459655. eCollection 2024. Front Pharmacol. 2024. PMID: 39355779 Free PMC article. Review.
-
Comparative in silico analysis of CNS-active molecules targeting the blood-brain barrier choline transporter for Alzheimer's disease therapy.In Silico Pharmacol. 2024 Jul 31;12(2):71. doi: 10.1007/s40203-024-00245-w. eCollection 2024. In Silico Pharmacol. 2024. PMID: 39099798
-
Effect of VAChT reduction on lung alterations induced by exposure to iron particles in an asthma model.J Inflamm (Lond). 2024 Jul 3;21(1):24. doi: 10.1186/s12950-024-00399-6. J Inflamm (Lond). 2024. PMID: 38961398 Free PMC article.
-
Innovative Formulation Platform: Paving the Way for Superior Protein Therapeutics with Enhanced Efficacy and Broadened Applications.Adv Mater. 2024 Oct;36(41):e2403116. doi: 10.1002/adma.202403116. Epub 2024 Jun 16. Adv Mater. 2024. PMID: 38819929 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
